The Patent Finder

B Cell Maturation Antigen (BCMA) BINDING PROTEINS

Glaxo Group Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/EP2012/059762, filed May 24, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,466,893Antigen Binding Proteins
In force
 · Medium confidence
UsedRemaining
Glaxo Group LimitedIn forceMedium confidence
US 11,419,945Antigen Binding Proteins
In force
 · Medium confidence
Glaxo Group LimitedIn forceMedium confidence
US 9,273,141B Cell Maturation Antigen (BCMA) BINDING PROTEINS
In force
 · Medium confidence
Glaxo Group LimitedIn forceMedium confidence
Application 14/122,391Bcma (CD269/TNFRSF17) - Binding Proteins
Abandoned
Abandoned May 16, 2016
Glaxo Group LimitedAbandonedAbandoned May 16, 2016
Application 14/974,675Antigen Binding Proteins
Abandoned
Abandoned Nov 5, 2018
Glaxo Group LimitedAbandonedAbandoned Nov 5, 2018
Application 15/828,770Antigen Binding Proteins
Abandoned
Abandoned Aug 17, 2020
Glaxo Group LimitedAbandonedAbandoned Aug 17, 2020
Application 19/357,306Antigen Binding Proteins
Pending
Not granted
Glaxo Group LimitedPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Glaxo Group Limited.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited